Styrene oxide
CAS No. 96-09-3
Styrene oxide( —— )
Catalog No. M19497 CAS No. 96-09-3
Styrene oxide is an epoxide derived from styrene. It can be prepared by epoxidation of styrene with peroxybenzoic acid.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameStyrene oxide
-
NoteResearch use only, not for human use.
-
Brief DescriptionStyrene oxide is an epoxide derived from styrene. It can be prepared by epoxidation of styrene with peroxybenzoic acid.
-
DescriptionStyrene oxide is an epoxide derived from styrene. It can be prepared by epoxidation of styrene with peroxybenzoic acid.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorepoxide hydrolase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number96-09-3
-
Formula Weight120.15
-
Molecular FormulaC8H8O
-
Purity>98% (HPLC)
-
SolubilityDMSO:10 mM
-
SMILESC1OC1C1=CC=CC=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Shen S et al. Biotechnol Lett. 2013 Apr; 35(4):599-606.
molnova catalog
related products
-
Hydroxyamphetamine
Hydroxyamphetamine is an indirect-acting sympathomimetic amine with adrenergic property.
-
TH-263
TH-263 is inactive toward both LIMK1 and LIMK2 and thus can be used as negative control for TH-257, and is a diaryl sulfonamide derivative.
-
Parimifasor
Parimifasor(LYC-30937-EC, LYC30937) is an orally bioavailable, enteric-coated ATPase modulator as a gut-directed therapy for the treatment of inflammatory bowel disease (IBD).
Cart
sales@molnova.com